Anu

Anu Bio-pharmaceuticals is a biotechnology company focused on developing a first-in-class, multi-functional biologic response modifier designed to fortify the structure and functional persistence of the epithelium and endothelium. The company's proprietary technology acts as a disease-modifying, orally administered agent that modulates the host's principal response to disease by maintaining barrier integrity. This approach is applicable across a broad range of therapeutic areas, including respiratory, gastrointestinal, and urothelial conditions, as well as immuno-oncology and cardiovascular health. By addressing diminished epithelial-endothelial integrity, Anu Bio-pharmaceuticals aims to fill a significant treatment void and provide a new paradigm for reducing vulnerability to pathogens and limiting disease progression.